News
![Lungs-16-9](https://pharmaphorum.com/wp-content/uploads/2016/07/Lungs-16-9.jpg)
BenevolentAI, AstraZeneca AI-based drug discovery collaborat...
BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has added to its drug development portfolio, resulting in a milestone payment to the Lon